Adial Pharmaceuticals has announced the issuance of patent number 12,226,401, which enhances their genetic-based approach for treating alcohol and opioid use disorders. This new patent focuses on ...

Please provide your email address to receive an email when new articles are posted on . At 12 months, 7.1% of patients with AUD and cirrhosis in the naltrexone group vs. 28.6% in the placebo group had ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacologic therapies. While more research is needed, preclinical and ...

In a recent study published in the journal PLoS ONE, researchers investigated the effects of alcohol consumption and short-term abstinence on gut dysbiosis in individuals with Alcohol Use Disorder ...

Jesse Richards, director of Obesity Medicine and assistant professor of Medicine at OU-TU School of Community Medicine and lead author of the study. The first published evidence from humans that ...

Alcohol, tobacco and substance use are common among young adults; problematic alcohol use is especially prevalent on college campuses. There are a variety of factors that influence individual patterns ...